|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
||||||
|
|
|
|
|
|
|
|
||
|
|
||||||||
|
|
|
|
||||||
BREAST CARCINOMA IN-SITU AND HIGH RISK PATIENTS There are two types non-invasive breast cancers recognised on the basis of histological pattern; ductal carcinoma in-situ (DCIS) and lobular carcinoma in-situ (LCIS). DCIS is the commoner form and makes up to 5% of symptomatic and 18% of screen detected cancers. In contrast, LCIS constitutes only 0.5% of symptomatic and approximately 1% of screen detected cancers. Please choose from the following: Ductal carcinoma in situ - Lobular carcinoma in situ - High risk patients High Risk Factors for Breast Cancer. There are a number of factors which have been identified as risk factors. Some of these are associated with a slightly elevated risk (< 2times) and are of no clinical significance requiring no action. Age at first pregnancy, history of breast feeding and diet are among low risk factors. There are only two factors which would suggest a need for clinical surveillance are history of certain types of benign breast disease and family history.
Women with atypical hyperplasia are at significantly increased risk of developing breast cancer. There is a further interaction between atypical hyperplasia and family history. Women who have a first degree relative with breast cancer and atypical hyperplasia on breast biopsy have up to 30% absolute risk of developing breast cancer within next 15 - 20 years. If
you require further advice or information please contact the |
||||||||||||
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
|